Biochemistry, Genetics and Molecular Biology
DNA
76%
Spectrum
63%
Mycobacterium Tuberculosis
54%
Mammalian Cell
54%
Clinical Trial
54%
Introspection
54%
Immune Response
54%
Raman Microscopy
54%
Host
54%
Topoisomerase
51%
Escherichia coli
36%
Gram Negative Bacterium
36%
Electric Potential
27%
Gyrase
25%
Non-Ionic Surfactant
23%
Mouse
23%
Quantitative Imaging
18%
Bacterial Growth
18%
Comprehension
18%
Microscopy
18%
Fluorescence
18%
Melting Point
18%
Nuclear Magnetic Resonance Spectroscopy
18%
Topoisomerase IV
18%
Cell-Cell Interaction
18%
Electrospray Mass Spectrometry
18%
Infectious Agent
18%
Recognition
18%
Solution and Solubility
18%
Imaging Technique
18%
Gram Positive Bacterium
18%
Staphylococcus Aureus
18%
DNA Binding
15%
Drug Screening
9%
Lysosome
9%
Development
9%
Binding Affinity
9%
Process Design
9%
Raman Spectroscopy
9%
DNA Damage
7%
Reduction (Chemistry)
7%
Flow Cytometry
7%
Proinflammatory Cytokine
7%
Immunocompetent Cell
7%
Mass Spectrometry
7%
Medicine and Dentistry
Mechanism of Action
62%
Assay
62%
Host
54%
Tuberculosis
54%
Immune Response
54%
Topoisomerase
51%
Mycobacterium Tuberculosis
46%
Escherichia coli
36%
Therapeutic Procedure
36%
Interference
25%
Dimer
25%
Relaxation
25%
Niosome
23%
Gram-Positive Bacteria
18%
Effusion
18%
Intercalating Agent
18%
Electrospray Mass Spectrometry
18%
Tenidap
18%
Disease
18%
Recognition
18%
Nuclear Magnetic Resonance Spectroscopy
18%
Antibiotics
18%
Amoxicillin
18%
Bacterial Growth
18%
Staphylococcus Aureus
18%
DNA Topoisomerase IV
18%
Pathogen
18%
Quinolone Derivative
18%
Gram-Negative Bacteria
18%
Organism
18%
DNA Binding
15%
Multimodal Imaging
9%
Alkyne
9%
Morpholine
9%
Flow Cytometry
7%
Mass Spectrum
7%
Intranasal Drug Administration
7%
Lung
7%
Cytokine
7%
Immunocompetent Cell
7%
Histology
7%
Combination Therapy
7%
Enzyme Linked Immunosorbent Assay
7%
Neutrophil
7%
DNA Damage
7%
Pharmacology, Toxicology and Pharmaceutical Science
DNA
100%
Host
54%
Antitubercular Activity
54%
Tuberculosis
54%
DNA Topoisomerase
51%
Mycobacterium Tuberculosis
46%
Drug
36%
Gram Negative Bacterium
36%
Escherichia coli
36%
Dimer
25%
Mouse
23%
Niosome
23%
Tenidap
18%
Quinolone Derivative
18%
Diseases
18%
Staphylococcus Aureus
18%
Gram Positive Bacterium
18%
Amoxicillin
18%
Infectious Agent
18%
DNA Topoisomerase IV
18%
Electrospray Ionization
18%
Antibiotics
18%
Intercalating Agent
18%
Drug Development
18%
Effusion
18%
Alkyne
9%
Drug Screening
9%
Morpholine
9%
Drug Discovery
9%
Amidinium
9%
Cytokine
7%
Enzyme-Linked Immunosorbent Assay
7%
Flow Cytometry
7%
Chemokine
7%
Biological Product
7%